Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 3:32 PM UTC
| NCT Number | NCT04566328 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 1,450 participants |
| Active Locations | 642 sites in the US |
| Sponsor | ECOG-ACRIN Cancer Research Group |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of July 19, 2026: Clinical trial NCT04566328 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 642 locations across the United States. The study is sponsored by ECOG-ACRIN Cancer Research Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04566328 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 642 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04566328 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.